New England Fertility Institute (NEFI) is located in Stamford, Connecticut, a major city on the southwestern edge of the state that sits roughly 30 miles northeast of Midtown Manhattan. Stamford's position at the crossroads of Fairfield County and the broader New York metropolitan area means NEFI serves a diverse patient base — including Connecticut residents, commuters who work in New York City, and patients from nearby Westchester County who prefer Connecticut-licensed care. For a full look at fertility options across the state, visit the Connecticut fertility clinics directory.
Physicians and Clinical Team
New England Fertility Institute has a well-established reputation in the Connecticut and tri-state region, having operated for several decades. The practice has historically been associated with physicians who trained at leading academic reproductive medicine programs and who hold board certification in Reproductive Endocrinology and Infertility through ABOG. REI specialists undergo extensive fellowship training in endocrine disorders affecting reproduction, surgical management of uterine and tubal pathology, and the science of embryology and gamete cryopreservation.
The clinical team at NEFI typically combines experienced reproductive endocrinologists with reproductive surgery capabilities, allowing treatment of complex uterine and tubal factor cases — including endometriosis, fibroids, and Asherman's syndrome — without requiring referral to an outside surgical center. An in-house embryology laboratory staffed by certified embryologists is central to the practice's IVF program.
Services and Treatments
NEFI provides a broad range of reproductive medicine services:
- IVF (In Vitro Fertilization) — individualized stimulation protocols with laboratory-based fertilization and embryo culture
- IUI (Intrauterine Insemination) — medicated and natural-cycle options for appropriate candidates
- Egg Freezing — elective fertility preservation and oncofertility preservation for patients facing cancer treatment
- Preimplantation Genetic Testing (PGT-A and PGT-M) — embryo biopsy and chromosomal screening to identify euploid embryos prior to transfer
- Frozen Embryo Transfer (FET) — natural-cycle and hormone-replacement FET protocols
- Donor Egg IVF — anonymous and known-donor programs
- Donor Sperm Services
- Gestational Surrogacy — third-party coordination for patients using a gestational carrier
- Male Infertility Evaluation — including semen analysis and referral for urological workup
- Recurrent Pregnancy Loss Workup — immunologic, thrombophilic, anatomical, and genetic evaluation
- Minimally Invasive Reproductive Surgery — laparoscopy and hysteroscopy for endometriosis, fibroids, and uterine adhesions
Laboratory and Success Rates
Laboratory quality is the most critical non-physician variable in IVF outcomes. An experienced embryology team using current culture media, time-lapse monitoring systems, and rigorously validated vitrification protocols produces embryos that survive the freeze-thaw cycle at high rates — a key determinant of cumulative live birth success.
NEFI's long operational history suggests accumulated embryology expertise, though patients should always verify current laboratory performance through publicly available reporting rather than relying on historical reputation alone.
Patients should review the most current cycle-level data published by the CDC's ART Surveillance program and the SART Clinic Summary Report.
Patient Experience
Stamford is a highly accessible city for Fairfield County residents, with direct Metro-North rail service to Grand Central Terminal and convenient access from I-95 and the Merritt Parkway. For NEFI patients who live in Greenwich, Darien, Norwalk, or across the border in New York's Westchester County, the Stamford location offers a manageable commute even during the frequent monitoring appointments required during an IVF stimulation cycle.
The tri-state population NEFI serves is demographically diverse — encompassing finance, healthcare, and media professionals — and the clinic's experience with complex donor egg cycles and gestational surrogacy reflects the needs of a sophisticated, educated patient base. Patients who travel from outside the immediate area for consultations should confirm whether the clinic can coordinate with a local monitoring facility near their home address to reduce travel burden during the injection phase of an IVF cycle.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
Connecticut is one of a small number of states with a comprehensive IVF insurance mandate. Connecticut law requires insurance plans regulated by the state to cover medically necessary infertility treatment, including IVF, for eligible patients. Key provisions include:
- Coverage applies to fully insured health plans issued in Connecticut
- Patients must meet the clinical definition of infertility (typically 12 months of unprotected intercourse without conception, or 6 months for women over 35)
- The mandate covers IVF, IUI, egg freezing for medical reasons, and related diagnostic testing
- Self-insured employer plans (governed by federal ERISA law) are not subject to Connecticut's mandate
For patients with Connecticut-regulated insurance, NEFI's billing team can verify specific benefit coverage and out-of-pocket obligations. Patients whose employers are self-insured should check their Summary Plan Description and contact HR directly.
Frequently Asked Questions
Does Connecticut's IVF mandate cover same-sex couples and single individuals? Connecticut's infertility coverage law has been interpreted broadly and has been updated over time to be more inclusive. Same-sex couples and single individuals may qualify under the mandate's definition of infertility, though specific coverage terms can vary by plan. Consulting with NEFI's insurance coordinator and requesting a formal benefits verification is the recommended first step.
What is PGT-A and should I consider it for my IVF cycle? Preimplantation Genetic Testing for Aneuploidy (PGT-A) screens embryos for chromosomal abnormalities before transfer. It can reduce miscarriage rates and improve the odds that a transferred embryo will result in a live birth — particularly for patients over 37, those with recurrent pregnancy loss, or those with prior failed transfers. It adds cost to a cycle and involves an embryo biopsy. Your REI physician can advise whether PGT-A is appropriate based on your age, ovarian reserve, and history.
How does NEFI handle patients who live in New York but want treatment in Connecticut? Many patients cross state lines for fertility care due to proximity, preference, or referral. NEFI's Connecticut location means treatment is governed by Connecticut's laws and licensing requirements. For New York residents using New York-regulated insurance, Connecticut-based care may or may not be in-network — patients should verify coverage with their insurer before committing to treatment there.
Can I freeze my eggs at NEFI if I'm not yet ready to try to conceive? Yes. Elective egg freezing (oocyte cryopreservation) is available for patients who want to preserve their reproductive potential for future use. The ideal candidates are women in their late 20s to mid-30s before significant age-related egg quality decline occurs. A consultation typically involves ovarian reserve testing (AMH and antral follicle count) to estimate how many eggs a stimulation cycle is likely to yield.